News and blogs
20 results found.
Over a third of people with blood cancer “haven’t had shielding letter”
Our survey found that over a third of people with blood cancer who are expecting to get a letter telling them to stay at home and shield because of the coronavirus have not yet received one.
People with undiagnosed blood cancer don't know they're vulnerable to coronavirus
There are over 10,000 people with undiagnosed blood cancer who are extremely vulnerable to the coronavirus, but don't know it.
Could a blood cancer drug be used to help people with COVID-19?
Calquence is being trialled in patients with COVID-19 who are critically ill, in the hope that it may reduce damage to their lungs.
Five charities call for supermarkets to sign up to key pledges
We've written to supermarkets with six key pledges, to ensure people with blood cancer and other vulnerable people shielding for 12 weeks can get food deliveries.
Call for supermarkets to prioritise people with blood cancer for online orders
We've written to the government and six major supermarkets, calling on them to take urgent action to make sure people with blood cancer can get food deliveries.
It's not a big day today, but it's been a big couple of years
When I joined this organisation, I said we never would change our name, writes our CEO Gemma Peters
Our new name
As of today, we have changed our name from Bloodwise to Blood Cancer UK.
Charities keep people well - we need government help too
The coronavirus emergency has increased demand for the third sector, while crushing its ability to raise funds, writes our CEO Gemma Peters.
Leukaemia protective role of Y chromosome gene discovered
Scientists funded by Bloodwise have discovered the first leukaemia protective gene that is specific to the male-only Y chromosome. Researchers at the Wellcome Sanger Institute and the University of Cambridge found that this Y-chromosome gene protects against the development of acute myeloid leukaemia (AML) and other cancers.
What causes leukaemia and how can we use this information to better treat it?
How does the immune system recognise and destroy Hodgkin lymphoma?
In Hodgkin lymphoma, the cells which are the root cause of the cancer are hidden within a much larger number of white blood cells. These white blood cells are usually very good at killing cancer cells, but may be unable to kill all of the Hodgkin lymphoma cells. Bloodwise Visiting Fellow Dr Zumla Cader has been investigating why...
Beating blood cancer: how decades of research makes us excited about the future
Last week Professor Pamela Kearns, one of the UK’s leading blood cancer researchers, gave a talk at St James’s Palace about the progress we’ve made in blood cancer research, and why we believe blood cancer can be beaten in the next few decades.
How did a weapon of war become a blood cancer treatment?
As we pay tribute to the soldiers of World War I, we look at the surprising link between the battlefields of France and blood cancer research.
New tool to find and fight most dangerous types of lymphoma
UK scientists funded by Bloodwise have found a new way to identify people with lymphoma who are less likely to respond to standard drugs.
ASH Annual Meeting 2018 round-up: the latest CAR-T therapy news
This week, the American Society of Hematology (ASH) Annual Meeting saw 30,000 experts gather in San Diego to discuss new research and clinical experience examining blood cancers and other blood disorders. In part one of our round-up, read about the latest breakthroughs in CAR-T therapy – a game changing new treatment for blood cancer.
Simon Thomas takes on President role at Bloodwise
TV presenter Simon Thomas has announced that he has been made a President at Bloodwise.
We’re changing to Blood Cancer UK
Bloodwise will be changing its name to Blood Cancer UK in Spring 2020.
What the election result means for people affected by blood cancer
Now we know the result, which gives the Conservatives a sufficient majority to enact their manifesto. This is what we think politicians should do to help the blood cancer community.
Watch the highlights from Meet the Scientists 2019
The event was an opportunity to hear about the latest updates in treatments and technologies.
Over a quarter of blood cancer cases only diagnosed after emergency admission
Thousands of people a year in England only learn they have blood cancer, such as leukaemia, lymphoma and myeloma, after their symptoms need emergency treatment according to our new report.
